欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/H/0511/001
药品名称IZINOVA, concentrate for oral solution
活性成分
    • Magnesium sulfate 3.28 g
    • Potassium sulfate 3.13 g
    • Sodium sulfate 17.51 g
剂型Concentrate for oral solution
上市许可持有人IPSEN PHARMA 65 quai Georges Gorse 92100 BOULOGNE BILLANCOURT FRANCE
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • Germany (DE)
      Izinova 24 g-Flasche Lösung zum Einnehmen
    • Belgium (BE)
      Eziclen
    • Netherlands (NL)
      Eziclen, concentraat voor drank
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
      Izinova
    • Latvia (LV)
    • Lithuania (LT)
      Eziclen koncentratas geriamajam tirpalui
    • Estonia (EE)
      EZICLEN
    • Czechia (CZ)
      Eziclen koncentrát pro perorální roztok
    • Romania (RO)
      Eziclen Concentrat pentru soluţie orală
许可日期2013/01/17
最近更新日期2025/01/27
药物ATC编码
    • A06AD10 mineral salts in combination
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase